Hoey Investments’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$18.2K Hold
300
﹤0.01% 212
2025
Q4
$16.2K Hold
300
﹤0.01% 223
2025
Q3
$13.5K Hold
300
﹤0.01% 236
2025
Q2
$13.9K Hold
300
﹤0.01% 220
2025
Q1
$18.3K Hold
300
﹤0.01% 183
2024
Q4
$17K Hold
300
﹤0.01% 186
2024
Q3
$12.5K Hold
300
﹤0.01% 192
2024
Q2
$12.5K Hold
300
﹤0.01% 192
2024
Q1
$16.3K Sell
300
-211
-41% -$10.7K ﹤0.01% 186
2023
Q4
$26.2K Hold
511
0.01% 155
2023
Q3
$29.7K Hold
511
0.01% 149
2023
Q2
$32.7K Hold
511
0.01% 147
2023
Q1
$35.4K Hold
511
0.01% 148
2022
Q4
$36.8K Buy
511
+211
+70% +$15.9K 0.02% 147
2022
Q3
$21K Hold
300
0.01% 186
2022
Q2
$23K Hold
300
0.01% 150
2022
Q1
$22K Sell
300
-300
-50% -$20.1K 0.01% 135
2021
Q4
$37K Sell
600
-300
-33% -$17.6K 0.01% 120
2021
Q3
$53K Buy
+900
New +$59.3K 0.02% 105
2020
Q3
Sell
-51,647
Closed -$3.04M 135
2020
Q2
$3.04M Buy
51,647
+3,414
+7% +$204K 1.49% 13
2020
Q1
$2.69M Buy
48,233
+6,320
+15% +$386K 1.89% 11
2019
Q4
$2.69M Buy
+41,913
New +$2.4M 1.91% 18

Other funds holding BMY

Hoey Investments's BMY Position: Q1 2026 in Review

Hoey Investments held its Bristol-Myers Squibb (BMY) position steady in Q1 2026 at 300 shares worth $18.2K. The position accounts for ﹤0.01% of the portfolio, ranked #212.

Hoey Investments first reported a position in BMY in Q4 2019 and has held it in 22 quarters since. The position peaked at $3.04M in Q2 2020. 2,519 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • Hoey Investments held 300 shares of Bristol-Myers Squibb worth $18.2K as of Q1 2026.
  • Hoey Investments left its Bristol-Myers Squibb share count unchanged in Q1 2026.
  • Bristol-Myers Squibb made up ﹤0.01% of Hoey Investments's portfolio in Q1 2026, its #212 holding.
  • Hoey Investments first reported a position in Bristol-Myers Squibb in Q4 2019 and has held it in 22 quarters since.
  • Hoey Investments's Bristol-Myers Squibb position peaked at $3.04M in Q2 2020.
  • 2,519 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Hoey Investments's 13F filing for Q1 2026, filed 29 Apr 2026.